Stahl Neil's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 12, 2024
- Accession no.
- 0001968202-24-000115
- Filed
- Aug 12, 2024
- Trade date
- Aug 8-12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $5.64M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stahl NeilCIK 0001226689 | Officer (EVP Research and Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | Common Stock | SSaleDisposed | −100 | $1,081.83F1 | −$108,183 | 56,096 | Direct | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −200 | $1,082.69F2 | −$216,538 | 55,896 | Direct | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −1,006 | $1,083.76F3 | −$1,090,262.56 | 54,890 | Direct | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −1,883 | $1,084.61F4 | −$2,042,320.63 | 53,007 | Direct | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −1,708 | $1,085.01F5 | −$1,853,197.08 | 51,299 | Direct | |
| Aug 8, 2024 | Common Stock | SSaleDisposed | −300 | $1,086.15F6 | −$325,845 | 50,999 | Direct | |
| Aug 12, 2024 | Common Stock | GGiftDisposed | −900 | $0.00 | $0 | 50,099 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.